Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001641172-25-014021
Filing Date
2025-06-06
Accepted
2025-06-06 16:05:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5171
  Complete submission text file 0001641172-25-014021.txt   7272
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Subject) CIK: 0000862861 (see all company filings)

EIN.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-42213 | Film No.: 251030535
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address TEMPLETON BUILDING WEST BAY STREET NASSAU BAHAMAS Bahamas N-3901
Business Address TEMPLETON BUILDING WEST BAY STREET NASSAU BAHAMAS Bahamas N-3901 242 457-0001
Clover Crest Bahamas Ltd (Filed by) CIK: 0002071768 (see all company filings)

EIN.: 000000000 | State of Incorp.: C5 | Fiscal Year End: 1231
Type: SCHEDULE 13G